March 6, 2025—Vitestro unveiled its CE-marked Aletta Autonomous Robotic Phlebotomy Device. Using AI-driven ultrasound guidance, robotic precision, and full automation, Aletta is designed to perform the entire blood draw process, from applying a tourniquet and preparing the skin to vein identification, venipuncture, automated tube handling, and bandage application. The device integrates advanced AI-driven Doppler ultrasound technology to optimize vein selection and needle placement, aiming to enhance clinical efficiency, address workforce shortages, and improve the patient experience.
Vitestro, headquartered in the Netherlands, is preparing for broader adoption of Aletta across hospitals and laboratories throughout Europe. The company is also working toward U.S. regulatory approval and conducting a U.S.-based multicenter clinical trial in collaboration with leading academic medical centers and health care systems.